People with atopic dermatitis have a new treatment option. Today, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for .
Treatment. People with Atopic Dermatitis Have a New Treatment Option. On December 14, the U.S. Food and Drug Administration approved Eucrisa .
These breakthroughs are leading to new treatments. The U.S. Food and Drug Administration (FDA) has approved two medications, and more than 40 possible
The FDA recently approved a novel drug, crisaborole (Eucrisa), for the treatment of mild to moderate AD in adults and children greater than the age of two.